MKI67 and neoplasm: The inhibition of NKG2DL by antibodies led to increased CD8+ T cells expressing IFN-γ, Ki-67, and CD107 markers, suggesting that ligand inhibition in this case can reverse immunosuppression and counter a tumour-friendly TME [28].